The global spinal implant market, including the US, Europe and Asia Pacific, was valued at over $5 billion in 2008 and will grow to more than $7.5 billion in 2013, according to the release. The market’s top five companies collectively owned nearly 78 percent of the global market in 2008.
The report showed that although the top spine companies dominate the nonfusion segment, greater product availability and choice will change competitive dynamics in the industry in the coming years. Currently, spine surgeons have limited choices when opting for nonfusion devices, particularly in the US. However, MRG predicts that the range of options will expand as more entrants with improved devices as well as new technologies enter the spinal nonfusion market.
“Some of the soon-to-be-released artificial discs, such as Spinal Motion’s Kineflex and Kineflex-C as well as Cervitech/NuVasive’s PCM, possess innovative features that improve upon devices currently on the market,” Kevin Flewwelling, manager of the orthopedics division at MRG, said in the release. “If a new device from a smaller competitor enters the market and is well-received by surgeons, it could result in very interesting competitive dynamics, possibly leading to a flurry of merger and acquisition activity.”
Read the release about MRG’s Global Competitor Insights for Spinal Implants 2009 report.
To receive the orthopedic and spine news and feature stories from Becker’s Orthopedic & Spine Review, sign-up for the free Becker’s Orthopedic & Spine Review E-weekly by clicking here.
